These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37676033)

  • 1. Drug safety in Africa: a review of systems and resources for pharmacovigilance.
    Ndagije HB; Walusimbi D; Atuhaire J; Ampaire S
    Expert Opin Drug Saf; 2023; 22(10):891-895. PubMed ID: 37676033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.
    Adedeji-Adenola H; Nlooto M
    Int J Clin Pharm; 2021 Feb; 43(1):11-24. PubMed ID: 32902780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.
    Isah AO; Opadeyi AO; Tumwijukye H; Cobelens F; Smith D; Ndomondo-Sigonda M; Harmark L; Tanui P; Tiemersma E; Mmbaga BT; Mahlangu G; Ayinbuomwan SA; Soulaymani R; Pandit JM
    Ther Adv Drug Saf; 2023; 14():20420986231188836. PubMed ID: 37529763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new paradigm in adverse drug reaction reporting: consolidating the evidence for an intervention to improve reporting.
    Li R; Curtis K; Zaidi ST; Van C; Castelino R
    Expert Opin Drug Saf; 2022 Sep; 21(9):1193-1204. PubMed ID: 36031811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach.
    Sabblah GT; Seaneke SK; Kushitor M; van Hunsel F; Taxis K; Duwiejua M; van Puijenbroek E
    PLoS One; 2022; 17(3):e0264699. PubMed ID: 35239736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa.
    Kiguba R; Olsson S; Waitt C
    Br J Clin Pharmacol; 2023 Feb; 89(2):491-509. PubMed ID: 34937122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
    Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence in pharmacovigilance: Do we need explainability?
    Hauben M
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1311-1316. PubMed ID: 35747938
    [No Abstract]   [Full Text] [Related]  

  • 9. Intelligent Telehealth in Pharmacovigilance: A Future Perspective.
    Edrees H; Song W; Syrowatka A; Simona A; Amato MG; Bates DW
    Drug Saf; 2022 May; 45(5):449-458. PubMed ID: 35579810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence-Based Pharmacovigilance in the Setting of Limited Resources.
    Liang L; Hu J; Sun G; Hong N; Wu G; He Y; Li Y; Hao T; Liu L; Gong M
    Drug Saf; 2022 May; 45(5):511-519. PubMed ID: 35579814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale.
    Rachlis B; Karwa R; Chema C; Pastakia S; Olsson S; Wools-Kaloustian K; Jakait B; Maina M; Yotebieng M; Kumarasamy N; Freeman A; de Rekeneire N; Duda SN; Davies MA; Braitstein P
    Drug Saf; 2016 Oct; 39(10):959-76. PubMed ID: 27282427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific features of medicines safety and pharmacovigilance in Africa.
    Isah AO; Pal SN; Olsson S; Dodoo A; Bencheikh RS
    Ther Adv Drug Saf; 2012 Feb; 3(1):25-34. PubMed ID: 25083223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data.
    Martin GL; Jouganous J; Savidan R; Bellec A; Goehrs C; Benkebil M; Miremont G; Micallef J; Salvo F; Pariente A; Létinier L;
    Drug Saf; 2022 May; 45(5):535-548. PubMed ID: 35579816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and Tanzania.
    Barry A; Olsson S; Minzi O; Bienvenu E; Makonnen E; Kamuhabwa A; Oluka M; Guantai A; Bergman U; van Puijenbroek E; Gurumurthy P; Aklillu E
    Drug Saf; 2020 Apr; 43(4):339-350. PubMed ID: 31919794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
    Jusot V; Chimimba F; Dzabala N; Menang O; Cole J; Gardiner G; Ofori-Anyinam O; Oladehin O; Sambakunsi C; Kawaye M; Stegmann JU; Guerra Mendoza Y
    Drug Saf; 2020 Jun; 43(6):583-593. PubMed ID: 32239447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacovigilance activities in ASEAN countries.
    Suwankesawong W; Dhippayom T; Tan-Koi WC; Kongkaew C
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1061-9. PubMed ID: 27174034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of listening social media for pharmacovigilance purposes: a systematic review.
    Convertino I; Ferraro S; Blandizzi C; Tuccori M
    Expert Opin Drug Saf; 2018 Nov; 17(11):1081-1093. PubMed ID: 30285501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Intelligence in Pharmacovigilance and COVID-19.
    Bhardwaj K; Alam R; Pandeya A; Sharma PK
    Curr Drug Saf; 2023; 18(1):5-14. PubMed ID: 35382726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.
    Olsson S; Pal SN; Stergachis A; Couper M
    Drug Saf; 2010 Aug; 33(8):689-703. PubMed ID: 20635827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.